Trametinib-d4 is the deuterium labeled Trametinib. Trametinib (GSK1120212, JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2].
Molecular Weight:
619.42
Formula:
C26H19D4FIN5O4
Target:
Apoptosis,Autophagy,MEK
Application Notes:
Isotope-Labeled Compounds
* VAT and and shipping costs not included. Errors and price changes excepted
